Rioprostil in the short-term treatment of duodenal ulcer: a multicentre double-blind trial vs. cimetidine. 1989

G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
Gastrointestinal Unit, L. Sacco Hospital, Milan, Italy.

The efficacy and safety of the new prostaglandin E1 (PGE1) synthetic analogue, rioprostil, 300 micrograms b.d. and cimetidine, 400 mg b.d., on duodenal ulcer healing are compared in an international, multicentre, double-blind study. A total of 257 patients have entered the study; 243 are considered eligible for efficacy analysis and 207 for safety analysis. After 4 and 6 weeks of treatment, the endoscopic healing rates do not significantly differ between the two groups, being 55% and 83% respectively with rioprostil vs. 60% and 78% respectively with cimetidine. The major adverse effect attributable to rioprostil is diarrhoea, which was documented in 11% of patients compared with 1% of patients taking cimetidine. However, central nervous system complaints are twice as frequent in the cimetidine group. Monitoring of clinical laboratory tests show no significant abnormalities when compared with the baseline values during the administration of either drug. This study documents that rioprostil, at the dosage of 300 micrograms b.d., is as effective and safe as cimetidine in the short-term therapy of duodenal ulcer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011465 Prostaglandins, Synthetic Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity. PG Analog,PG Analogs,Prostaglandin Analog,Prostaglandin Analogs,Prostaglandin Analogue,Synthetic Prostaglandin,Prostaglandin Analogues,Synthetic Prostaglandins,Analog, PG,Analog, Prostaglandin,Analogs, PG,Analogs, Prostaglandin,Analogue, Prostaglandin,Analogues, Prostaglandin,Prostaglandin, Synthetic
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer

Related Publications

G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
January 1989, Scandinavian journal of gastroenterology. Supplement,
G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
January 1989, Scandinavian journal of gastroenterology. Supplement,
G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
December 1981, Hepato-gastroenterology,
G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
December 1980, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
July 1979, British medical journal,
G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
September 1979, The Journal of the Association of Physicians of India,
G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
March 1984, The Journal of the Association of Physicians of India,
G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
January 1982, Digestion,
G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
February 1981, Hepato-gastroenterology,
G Bianchi Porro, and F Parente, and E Hentschel, and A Bennani, and F Sebti, and A Cherkaoui, and M Demyttenaere, and H Gouerou, and A Blasi, and F Darnis
August 1989, The Journal of the Association of Physicians of India,
Copied contents to your clipboard!